BG20593A3 - Метод за получаване на тиено<3,2-д>пиримидини - Google Patents

Метод за получаване на тиено<3,2-д>пиримидини

Info

Publication number
BG20593A3
BG20593A3 BG020371A BG2037172A BG20593A3 BG 20593 A3 BG20593 A3 BG 20593A3 BG 020371 A BG020371 A BG 020371A BG 2037172 A BG2037172 A BG 2037172A BG 20593 A3 BG20593 A3 BG 20593A3
Authority
BG
Bulgaria
Prior art keywords
pyrimidines
thieno
obtaining
obtaining thieno
Prior art date
Application number
BG020371A
Other languages
Bulgarian (bg)
English (en)
Inventor
Berthold Narr
Josef Roch
Erich Muller
Josef Nickl
Original Assignee
Dr. Karl Thomae Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19712121950 external-priority patent/DE2121950A1/de
Priority claimed from DE19712137341 external-priority patent/DE2137341A1/de
Priority claimed from DE19722215299 external-priority patent/DE2215299A1/de
Application filed by Dr. Karl Thomae Gmbh filed Critical Dr. Karl Thomae Gmbh
Publication of BG20593A3 publication Critical patent/BG20593A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BG020371A 1971-05-04 1972-05-03 Метод за получаване на тиено<3,2-д>пиримидини BG20593A3 (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19712121950 DE2121950A1 (en) 1971-05-04 1971-05-04 Thieno(3,2-d)pyrimidine derivs - with thrombocyte aggregation inhibiting activity
DE19712137341 DE2137341A1 (de) 1971-07-26 1971-07-26 Neue thieno eckige klammer auf 3,2-d eckige klammer zu pyrimidine
DE19722215299 DE2215299A1 (de) 1972-03-29 1972-03-29 Neue thieno eckige klammer auf 3,2-d eckige klammer zu pyrimidine

Publications (1)

Publication Number Publication Date
BG20593A3 true BG20593A3 (bg) 1975-12-05

Family

ID=27183398

Family Applications (1)

Application Number Title Priority Date Filing Date
BG020371A BG20593A3 (bg) 1971-05-04 1972-05-03 Метод за получаване на тиено<3,2-д>пиримидини

Country Status (15)

Country Link
US (1) US3888851A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT318619B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU4181572A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE783044A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG20593A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD97656A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK129844B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES402302A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2135294B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1393161A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU163960B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL39341A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7206041A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL82381B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RO (1) RO62428A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054656A (en) * 1975-09-10 1977-10-18 Mead Johnson & Company Thieno[2,3-d]pyrimidine antiallergic agents
US5098902A (en) * 1991-03-18 1992-03-24 Warner-Lambert Company Method of treating neurodegenerative diseases
WO1993017021A1 (en) * 1992-02-19 1993-09-02 Pfizer, Inc. Heterocyclic compounds for enhancing antitumor activity
CN1279682A (zh) 1997-10-20 2001-01-10 霍夫曼-拉罗奇有限公司 双环激酶抑制剂
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
GB0423653D0 (en) 2004-10-25 2004-11-24 Piramed Ltd Pharmaceutical compounds
EP2060575A1 (de) * 2006-04-19 2009-05-20 Boehringer Ingelheim International GmbH Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
JP5546240B2 (ja) 2006-04-26 2014-07-09 ジェネンテック, インコーポレイテッド 医薬化合物
JP5291616B2 (ja) 2006-04-26 2013-09-18 ジェネンテック, インコーポレイテッド ホスホイノシチド3−キナーゼ抑制剤化合物およびその使用方法
DK2024372T3 (da) 2006-04-26 2010-09-20 Hoffmann La Roche Thieno[3,2-d]pyrimidin-derivat, der er egnet som P13K inhibitor
CL2007003523A1 (es) 2006-12-07 2008-08-22 Piramed Ltd Genentech Inc Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad de pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso en el tratamiento profilactico o terapeutico del cancer
AR064155A1 (es) 2006-12-07 2009-03-18 Piramed Ltd Compuestos de inhibidores de fosfoinositido-3 quinasa y metodos de uso
WO2009042607A1 (en) 2007-09-24 2009-04-02 Genentech, Inc. Thiazolopyrimidine p13k inhibitor compounds and methods of use
US8637519B2 (en) * 2007-10-19 2014-01-28 Boehringer Ingelheim International Gmbh Heterocycle-substituted piperazino-dihydrothienopyrimidines
JP5348725B2 (ja) * 2007-10-25 2013-11-20 ジェネンテック, インコーポレイテッド チエノピリミジン化合物の製造方法
GB0721095D0 (en) 2007-10-26 2007-12-05 Piramed Ltd Pharmaceutical compounds
EP2405916B1 (en) 2009-03-12 2018-02-07 Genentech, Inc. Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
BRPI1009022A2 (pt) 2009-05-27 2016-03-08 Hoffmann La Roche "composto, composição farmacêutica, processo para produzir uma composição farmacêutica, uso de um composto, método para tratamento de uma doença ou transtorno e kit"
EP2451811A1 (en) * 2009-05-27 2012-05-16 F. Hoffmann-La Roche AG Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
BR112012026470A2 (pt) 2010-04-16 2016-08-09 Genentech Inc método para prever a sensibilidade de crescimento de células tumorais e para tratar um tumor em um paciente
WO2012088254A1 (en) 2010-12-22 2012-06-28 Genentech, Inc. Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
EP2959014B1 (en) 2013-02-25 2019-11-13 Genentech, Inc. Methods and compositions for detecting and treating drug resistant akt mutant
GB201410816D0 (en) * 2014-06-17 2014-07-30 Ucb Biopharma Sprl And Katholieke Universiteit Leuven Therapeutic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3259623A (en) * 1963-06-14 1966-07-05 Olin Mathieson Process for preparing 2-(secondary amino)-halogenopyrimidines
DE1470356A1 (de) * 1964-01-15 1970-04-30 Thomae Gmbh Dr K Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung
US3210368A (en) * 1964-09-29 1965-10-05 Ciba Geigy Corp Certain 2-amino-4-aryl-5-n, n-disubstituted amino-lower alkyl-thiazole compounds

Also Published As

Publication number Publication date
US3888851A (en) 1975-06-10
BE783044A (fr) 1972-11-06
DK129844C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-05-12
FR2135294A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-12-15
NL7206041A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-11-07
DK129844B (da) 1974-11-25
IL39341A0 (en) 1972-07-26
IL39341A (en) 1975-08-31
AU4181572A (en) 1973-11-08
GB1393161A (en) 1975-05-07
AT318619B (de) 1974-11-11
DD97656A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-05-12
PL82381B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-10-31
RO62428A (fr) 1978-01-15
FR2135294B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-10-17
ES402302A1 (es) 1975-04-01
HU163960B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-11-28

Similar Documents

Publication Publication Date Title
BG20593A3 (bg) Метод за получаване на тиено&lt;3,2-д&gt;пиримидини
BG25647A3 (bg) Метод за получаване на пиримидини
BG22827A3 (bg) Метод за получаване на 1,2,4-триазол-нуклеозиди
BG17800A3 (bg) Метод за получаване на 2-(5-нитро-2-фурил)-тиено (3,2-d)пиримидини
BG19806A3 (bg) Метод за получаване на пиразоло-(1,5а)- пиримидини
BG17591A3 (bg) Метод за получаване на нови 2- аминоалкил амино- тиено /3,2-д пиримидини
BG18872A3 (bg) Метод за получаване на 4-амино-1,2,4-триазин-5-они
BG19166A3 (bg) Метод за получаване на тиено(3,2-д)-пиримидини
BG19800A3 (bg) Метод за получаване на 2(фурил-метил)-6,7-бензоморфани
BG19597A3 (bg) Метод за получаване на перидо/ 3,2-д/ пиримидини
BG17798A3 (bg) Метод за получаване на нови 2-аминоалкил-аминотиено (3,2-d)пиримидини
BG17560A3 (bg) Метод за получаане на 4,20, 22- буфатриеноли- драмнозид- етери
CH550151A (fr) Procede de preparation de nouvelles iodomethylsulfones.
BG20410A3 (bg) Метод за получаване на 3,4-дихидро-2н- изохинолин-1-они
BG20108A3 (bg) Метод за получаване на тиазоло (5,4-д)- пирамидини
BG20605A3 (bg) Метод за получаване на заместени &lt;2,3 д &gt; пиримидини
BE817147A (nl) Copolymerisatiewerkwijze
BE763014A (fr) Thieno (2,3-e)(1,4)diazepin-2-ones
BG23746A3 (bg) Метод за получаване на 4-амино 3,5-дихалоген-фенил-етаноламини
BG18864A3 (bg) Метод за получаване на карденоид-3-(2&#39;,3&#39;-дидезоксигликозиди)
BG21015A3 (bg) Метод за получаване на 1,3-диацетокси-2-метилен-пропан
BG17971A3 (bg) Метод за получаване на нови 2- аминоалкиламино тиено/ 3,2-д/ пиримидини
IT1025066B (it) Occhiali regolabili lateralmente
BR7406733A (pt) Cofragem de ombreira
BE781900A (fr) Nouvelles pyrido(3,2-d) pyrimidines